Close Menu

NEW YORK (GenomeWeb) – Enzo Biochem has sued Hologic again in federal court alleging patent infringement, Hologic said in its recently filed Form 10-Q. 

In the document filed with the US Securities and Exchange Commission, Hologic said that Enzo filed an additional lawsuit against it on March 27 in US District Court for the District of Delaware alleging certain Hologic molecular diagnostic products infringed US Patent No. 6,992,180, which is assigned to Enzo. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.